These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 10876856

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antibody Isolation in C. neoformans.
    Mendoza SR, da Silva Ferreira M, Valente MR, Guimarães AJ.
    Methods Mol Biol; 2024; 2775():307-328. PubMed ID: 38758326
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Monoclonal antibodies reactive with immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans.
    Brandt S, Thorkildson P, Kozel TR.
    Clin Diagn Lab Immunol; 2003 Sep; 10(5):903-9. PubMed ID: 12965925
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Monoclonal antibodies recognizing the capsular polysaccharide of Cryptococcus neoformans].
    Rodríguez Sánchez H, Pupo Antúnez M, Ilnait MT, Otero A, Martínez Machín G.
    Rev Cubana Med Trop; 2005 Sep; 57(2):162-4. PubMed ID: 17966590
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Monoclonal antibodies reveal additional epitopes of serotype D Cryptococcus neoformans capsular glucuronoxylomannan that elicit protective antibodies.
    Mukherjee J, Kozel TR, Casadevall A.
    J Immunol; 1998 Oct 01; 161(7):3557-68. PubMed ID: 9759877
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Monoclonal antibody to fungal glucosylceramide protects mice against lethal Cryptococcus neoformans infection.
    Rodrigues ML, Shi L, Barreto-Bergter E, Nimrichter L, Farias SE, Rodrigues EG, Travassos LR, Nosanchuk JD.
    Clin Vaccine Immunol; 2007 Oct 01; 14(10):1372-6. PubMed ID: 17715331
    [Abstract] [Full Text] [Related]

  • 14. Murine monoclonal antibodies recognizing a non-capsular antigen that distinguishes between Cryptococcus neoformans var. neoformans and C. neoformans var. gattii.
    Hamilton AJ, Bartholomew MA, Figueroa J, Fenelon LE, Hay RJ.
    Trans R Soc Trop Med Hyg; 1991 Oct 01; 85(1):123-7. PubMed ID: 2068741
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Genetic control of the humoral response to cryptococcal capsular polysaccharide in mice.
    Dromer F, Yeni P, Charreire J.
    Immunogenetics; 1988 Oct 01; 28(6):417-24. PubMed ID: 2460403
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Contribution of epitope specificity to the binding of monoclonal antibodies to the capsule of Cryptococcus neoformans and the soluble form of its major polysaccharide, glucuronoxylomannan.
    Duro RM, Netski D, Thorkildson P, Kozel TR.
    Clin Diagn Lab Immunol; 2003 Mar 01; 10(2):252-8. PubMed ID: 12626451
    [Abstract] [Full Text] [Related]

  • 20. Production and partial characterization of anti-Candida monoclonal antibodies.
    Chardès T, Piechaczyk M, Cavaillès V, Salhi SL, Pau B, Bastide JM.
    Ann Inst Pasteur Immunol (1985); 1986 Mar 01; 137C(2):117-25. PubMed ID: 2425714
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.